Abstract
Introduction

45
Protein engineering is an extremely useful tool in protein biotechnology for applications such as 46 protein stabilisation, re-assigning the catalytic properties of enzymes or increasing the interaction 47 affinity between antibody and target. However, a problem arises in the fact that for a protein of N 48 residues, the number of possible sequences is 20 N . Therefore, for a 300-residue protein the number 49 of possible sequences is 20 300 -effectively infinite possibilities. Even scaling this back to consider 50 just a small subset of positions for mutation provides a colossal number of potential mutations (the 51 mutation space), which remains a major problem for understanding protein folding and improving 52 protein function for biotechnological purposes. To date, strategies for protein engineering have 53 focussed on scanning (1), semi-systematic (2, 3), random (4), directed evolution (5) or 54 computational methods (6-8) for introducing new mutations. 55 Scanning mutagenesis has been particularly popular for the stabilisation of GPCRs and has 56 had highly successful outcomes for the structural elucidation of this extremely important class of 57 membrane protein (9). However, the process by which mutations are made and selected is an 58 expensive and labour-intensive process due to the fact that every amino acid position must be 59 mutated individually and tested for changes to protein behaviour (e.g. thermostability), and 60 therefore this approach has been somewhat exclusive to industry. Furthermore, scanning 61 techniques are limited to finding single positions at a time, and provide no information about 62 additive effects of combined mutations. Instead, amino acid positions initially identified by scanning 63 have traditionally been combined in a semi-systematic way (2), and from previous evidence it is 64 clear that combining single mutations together rarely provides a straight-forward additive effect (2).
Alternatively, mutagenesis can be performed randomly using techniques such as error prone 66 PCR (10) or mutator strains of E. coli (11). These random methods can be used for directed evolution 67 by multiple iterations of random mutagenesis followed by screening. However, these methods 68 requires the use of rapid, robust and high-throughput assays for evaluating mutational outcomes 69 (for example levels of GFP fluorescence (5)) and a method to link improvement in function to the 70 sequence that gave rise to it (for example cell sorting (5) or phage display (12)). However, not all 71 strategies are amenable to these approaches, as improvements in function may require complex 72 assays to ascertain. Furthermore, approaches that rely on error-prone PCR are limited due to several 73 compounding factors. Primarily, certain base-changes are more common than others (10), for 74 example A for T substitutions are more common than C for G substitutions (10). Secondly, a single 75 base-pair change to a codon is insufficient for one amino acid to be changed into all other amino 76 acids, for example, with a single base-pair change, alanine can be mutated to valine, threonine, 77 proline, serine, aspartate, glutamate or glycine, but not to anything else. Under conventional error-78 prone PCR methods, a double base-pair change in a single codon is statistically unlikely; therefore, 79 the kinds of changes that can be made to amino acid sequence using error-prone PCR are biased 80 and limited. 81
Computational methods for predicting and designing advantageous changes to protein 82 sequence are in their infancy (6). There have been several notable examples of where this approach 83 has been successful (7, 8), but often relies on pre-existing structural information (which is not always 84 available) and high-level thermodynamic calculations. Alternatively, deep sequencing information 85 has been exploited, for example the availability of homologs from thermophilic or thermotolerant 86 organisms has helped to successfully predict mutations for thermostabilisation of certain 87 membrane proteins (13). However, not all proteins of interest will have thermostable homologs in 88 nature. 89
Here, we intend to introduce a statistical method that will be widely applicable to protein 90 engineering, and pose some significant advantages over other approaches. Our key observation is 91 that each residue on average interacts with just three or four others, and most of the effects of 92 mutating a residue will be due to these local interactions. We can sample this space efficiently by 93 devising a mutation strategy that focuses only on minimal changes. Such a strategy is called a 94 fractional factorial design. A full factorial design would be one in which there are a number of 95
'factors' to be tested (i.e. interesting residue positions to mutate) each of which has a number of 96 discrete 'levels' (i.e. mutated or not mutated, or mutated to one of 20 amino acids) and every 97 combination of these levels across all factors would be tested. A fractional factorial design consistsof a carefully selected subset of the combinations available in a full factorial design, chosen to 99 exploit the sparsity-of-effects principal and reveal the most important information about the system 100 being studied. Helicobacter pylori over expressed in E. coli, 45% of crystal hits were discovered to be AcrB crystals 123 (20) . 124
The routine contamination of AcrB is in part due to the fact that levels of AcrAB transcription 125 are inversely proportional to the bacterial rate of growth (21). AcrB expression is therefore greatest 126 in the late stationary phase of growth, as induced by standard laboratory over-expression methods. 127
Furthermore, increasing the stringency of purification steps proven effective in the elimination of 128 other contaminants such as succinate dehydrogenase (20), fails for AcrB due to its particularly high 129 affinity for nickel, thus, making it very difficult to remove by conventional means, resulting in its co-130 purification alongside his-tagged proteins of interest. 131
Deleting the histadine rich C-terminus of AcrB has not been successful, and E. coli strains 132 with inactive AcrB (∆AcrB) tend to be more sensitive to antibiotics (22) a serious concern for the use 133 of over-expression systems. Therefore, a better approach is to introduce the minimal number of 134 changes required to reduce the affinity of E. coli AcrB to nickel sepharose resin to produce functional 135 AcrB with reduced affinity for nickel that can replace wild-type AcrB in E. coli expression strains. 136
Furthermore, success in this goal will demonstrate the validity and strengths of fractional factorial 137 design as a valuable tool for protein engineering. 138 139
Results
140
E. coli AcrB has eleven histidine residues per protomer (33 across the trimer), of which seven (H505, 141 H525, H526, H1042, H1044, H1048 and H1049) are clustered on the cytoplasmic proximal face (Fig.  142 1). Due to their proximity to one another and position on the surface of the protein these seven 143 histidine residues were selected as likely candidates for the innate affinity of AcrB for nickel. To 144 investigate the possible contribution of these residues to nickel binding, we used a fractional 145 factorial design to distinguish primary effects of individual mutations (main effects) from pairwise 146 effects of two residues acting together synergistically (two-way effects) ( Table 1) . 147 E. coli AcrB with an N-terminal GFP fusion was constructed and each combination of 148 mutations specified by the fractional factorial design was produced by site-directed mutagenesis 149 (Table 1) . Each construct was expressed in replicate in AcrB knockout E. coli and crudely purified on 150 small-scale nickel affinity columns in parallel. We were unable to obtain construct 14 at the time of 151 running the experiment, but due to the robust nature of the fractional factorial methodology, 152 missing values can be tolerated and therefore we proceeded regardless. The effect of histidine 153 mutants on the binding of AcrB to nickel resin could be observed by measuring in-gel GFP signals 154 ( Fig. 2 and Fig. S1) . 155
Statistical analysis of the relative amount of GFP fluorescence in the elution allowed us to 156 determine the main effects; we could determine which mutations to AcrB had the most significant 157 effect on nickel binding ( Table 2) . Refinement of the model was carried out to include only the most 158 significant main and two-way effects, confirming that these contributions were highly significant 159 (Table 3) . 160
The refined model ( Table 3 ) clearly shows that mutation of H505, H525, H1042 and H1044 161 have the most significant effect on reducing the affinity of E. coli AcrB for nickel (Fig. 3) . Notably, 162 the effects of each mutation are not additive, particularly in the case of H1044, which does not give 163 any further improvement in the presence of the other mutations, but can replace any one of themto give essentially identical effects (Table 4 ). This result suggests that a synergistic contribution of 165 the histidine residues is responsible for nickel binding, agreeing with the hypothesis that several 166 spatially close histidine residues are required for nickel ion coordination. Therefore, mutations to 167 H505, H525 and H1042 will produce E. coli AcrB with low affinity to nickel, but any one of these 168 mutations could be replaced by mutation of H1044 to get essentially the same result. 169
There is a caveat to add; due to the nature of the minimal design, we cannot be sure that 170 the large interactions we see are really due to the mutations they are labelled by. For example, the 171 interaction labelled H505:H1044, really estimates this plus H525:H526 plus H1042:H1049, but given 172 that the main effects of H526 and H1049 are close to zero, it would be a strange system that gave 173 this result. It would mean that, for example, H526 had a large beneficial effect in the absence of 174 H525 and a large detrimental effect in the presence of H525 and these two effects were of almost 175 exactly the same size. 176
To confirm that mutations to residues H505, H525, H1042 and H1044 could produce an AcrB 177 construct with reduced affinity for nickel, those mutations were combined, and an extensive 178 purification procedure was tested; washing the nickel sepharose resin with 10 column volumes of 179 wash buffer (Fig. 4) . There was significantly less (p > 0.01) AcrB eluted from nickel sepharose when 180 residues H505, H525, H1042 and H1044 were mutated to alanine in comparison to AcrB with wild-181 type sequence (Fig. 4) , most of the AcrB had eluted during the wash steps. This result confirms that 182 this combination of mutations are the optimum for creating a low nickel affinity AcrB construct. 183
184
Discussion
185
Here, we have demonstrated the use of fractional factorial design for protein design and 186 engineering. At the outset of the work the C-terminal residues (H1042, H1044, H1048 and H1049) 187 were suspected to be the main contributors to nickel sepharose binding (25), but there were also 188 histidine residues distant in sequence but spatially close to the C-terminus (H505, H525 and H526). 189
We tested a small subset of different specific combinations of alanine replacements at these seven 190 histidine residues in the native AcrB sequence designed in a fractional factorial screen ( Table 1) . 191
Statistical analyses of the results suggested that mutations of residues H505, H525, H1042 and 192 H1044 had the biggest effect on binding (Fig. 3) , and we confirmed this to be the case experimentally 193 (Fig. 4) . This novel result is in contrast with the originally held belief that only C-terminal residues 194 were important in nickel sepharose binding; the best combination of mutations could not be 195 predicted prior to the experiment.
We note that the residues important for nickel binding form two spatially close pairs; pair 197 H505:H525 and pair H1042:H1044 (Fig. 3) , and we hypothesise that these residues are at the correct 198 distance apart from one another to correctly coordinate the nickel ions. However, there are also 199 spatially close pairs of histidine residues that were not indicated to be important for nickel binding, 200 such as, H525:H526 and H1048:H1049. It is possible that histidine residues directly adjacent to one 201 another cannot adopt the correct geometry in order to correctly coordinate nickel ions. However, 202 this interpretation does not explain why H1044 which is ~27 Å distant from H505 and H525 in the 203 crystal structure appears to behave in a synergistic manner with all three of the other residues 204 indicated to be important (H505, H525 and H1042). One possibility is that any analysis based on the 205 crystal structure alone does not account for any flexibility of the C-terminus of AcrB in solution. sepharose, but reduced the amount of work and material costs by a factor of eight; we could 215 understand the effect of mutating everything in every combination while only having to perform an 216 eighth of that total experiment. Furthermore, we were able to handle the absence of results for one 217 of the tests in the series without losing information about the main effects, highlighting one of the 218 strengths of the fractional factorial methodology. This attribute of the fractional factorial design 219 would be highly desirable in high-throughput cloning campaigns as is generally required for protein 220 engineering, as absences of some mutations due to errors in cloning or expression can be ignored 221 without significant detriment to the understanding of main-effects in the system. 222
There would be significant room for expansion for this technique. Here, we have chosen a 223 system that was manageable on a small scale; however, with the use of high-throughput cloning 224 methods as often applied for other protein engineering applications there is no reason this 225 technique could not be expanded to cover an even larger mutational space. For example, here we 226 have concentrated on mutating each position to just one other residue (alanine), and a third amino 227 acid could easily be added without making the scale of the experiment too large to handle: for a fullfactorial of that experiment, 3 7 combinations would be required, but using fractional factorial design 229 the space could be sampled with just 82 combinations of mutants in a 1/27 experiment. 230
The specific use of fractional factorial design demonstrated here validates the use of this 231 method for protein engineering, and provides a framework to apply it broadly for many other 232 applications. For example, we believe this could have important application in the investigation of 233 altering enzyme active site residues to change affinity for substrate or alter substrate preference. In 234 the case of active site residues, it is often clear which residues form the most important interactions 235 with substrate to define specificity or catalytic activity, but unclear what combination of changes to 236 those residues (of the 20 amino acids) will have the desired effect on enzyme catalysis. We propose 237 that fractional factorial design would provide an excellent framework to allow comprehensive 238 understanding of the effect of changing all residues in an active site in all combinations, allowing 239 the sampling of a broad range of possible ways to modify the properties of the enzymatic reaction. 240
We also see a broad benefit of using fractional factorial design for altering the residues of 241 antibody complementarity determining regions (CDR) in order to improve the affinity of the 242 antibody for its epitope. Typically, antibody maturation and CDR improvement is done using random 243 mutagenesis. However, as discussed above, there are biases in random mutagenesis that will 244 prevent the full range of mutational space from being accessed. We propose that a fractional 245 factorial approach would allow a much broader sampling of the possible mutational space, and by 246 limiting mutation to just the CDRs the experiments will not be unfeasibly large. 247
In the case of protein stabilisation, fractional factorial design may not be able to replace 248 scanning or random mutagenesis methods for the initial identification of single positions with 249 beneficial effects to protein stability due to the staggering large number of possible combinations 250 even in a small protein. However, fractional factorial design can be extremely valuable to help 251 determine which of the mutations initially identified by other methods should be combined, and 252 suggesting the minimal number of changes required for maximal effect. 253
In combination with stability assays, we also envisage the use of fractional factorial design 254 to infer two-way effects (pairs of residues that do not have an additive effect) allowing us to 255 experimentally determine the proximity of residues to one another. This type of information can be 256 highly informative in proteins of unknown structure, as these residue pairs can act as distance 257 constraints for guiding and improving computationally derived protein models. 258
Materials and methods
260
Fractional factorial design 261
The E. coli AcrB residues H505, H525, H526, H1042, H1044, H1048 and H1049 were taken as the 262 seven factors for investigation, with two levels for each factor to be investigated (non-mutated; -263 or mutated to alanine; +) ( Table 5 ) 264 A 1/8 design was used (16 runs in the fractional factorial design vs 128 runs in the full 265 factorial design) (Table 1) , which can provide information about main effects and some two-way 266 effects can be inferred. 267 268
AcrB mutagenesis 269
The E. coli AcrB gene was cloned into a pET-21-GFP vector (pET-21-GFP-AcrB) to create the initial 270 GFP-tagged AcrB construct. Mutagenic primers were designed using either "QuickChange" or 271 "Round-the-Horn" methods (26). Mutations were introduced into AcrB sequentially as constructs 272 required between three and seven mutations in total. Briefly, 10 µL PCR reactions were setup using 273 mutagenic primers, Q5 DNA polymerase (NEB, Ipswich, USA) and the pET21-GFP-AcrB template (at 274 approximately 10 ng/µL). The reaction was carried out (Thermal Cycler, Bio-Rad, Hercules, USA) with 275 primer annealing temperatures determined theoretically, and a long elongation time (30 seconds 276 per kbp; 3.5 minutes). Following PCR the reactions were treated with either DpnI or a mixture of T4 277 DNA Ligase, T4 Polynucleotide Kinase and DpnI for the QuickChange or "Round-the-Horn" methods, 278
respectively (all enzymes were supplied by NEB, Ipswich, USA). These reactions were incubated at 279 room temperature for 1 hour before transformation into chemically competent OmniMAX E. coli 280 cells, plating on LB agar plates containing 100 µg/mL carbenicillin and overnight incubation at 37˚C. 281
Correctly mutated plasmids were confirmed by sanger sequencing (Eurofins genomics, Luxembourg, 282 Switzerland) after mini-prep plasmid purification (Nucleospin Plasmid kit; Macherey-Nagel, Düren, 283
Germany) from overnight culture of single colonies in LB containing 100 µg/mL ampicillin and 284 incubation at 37˚C. 285 286 AcrB expression and quantification of affinity for nickel 287
Chemically competent E. coli strain C41 ∆AcrB pRARE2 were transformed with the 16 pET-21-GFP-288
AcrB constructs using heat-shock method and plated onto LB agar plates containing 100 µg/mL 289 carbenicillin. Three single colonies were selected for each AcrB construct and used to inoculate 4 290 mL of auto-induction media (Na2HPO4, 10 mM, KH2PO4, 5 mM, tryptone, 0. 
